CTMX logo

CytomX Therapeutics (CTMX) Return On Equity

Annual ROE

-6988.82%
-6990.02%-582501.67%

December 31, 2024


Summary


Performance

CTMX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTMXprofitabilitymetrics:

Quarterly ROE

-146.84%
-105.50%-255.20%

December 31, 2024


Summary


Performance

CTMX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTMXprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

CTMX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-10000.0%0.0%
3 y3 years-127.7%-1213.3%
5 y5 years-4688.2%-1213.3%

CTMX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-127.7%at low-149.5%+82.5%
5 y5-year-127.7%at low-149.5%+82.5%
alltimeall time-127.7%at low-149.5%+94.7%

CytomX Therapeutics ROE History

DateAnnualQuarterly
Dec 2024
-6988.82%(<-9900.0%)
-146.84%(+255.2%)
Sep 2024
-
-41.34%(+50.7%)
Jun 2024
-
-27.44%(-10.6%)
Mar 2024
-
-30.70%(-3754.8%)
Dec 2023
1.20%(-99.0%)
0.84%(-93.6%)
Sep 2023
-
13.19%(-82.1%)
Jun 2023
-
73.80%(-75.1%)
Mar 2023
-
296.81%(-135.4%)
Dec 2022
115.82%(-99.5%)
-839.30%(+189.0%)
Sep 2022
-
-290.40%(+46.3%)
Jun 2022
-
-198.50%(+37.0%)
Mar 2022
-
-144.94%(-4.8%)
Dec 2021
25.24 K%(-8539.1%)
-152.29%(+25.6%)
Sep 2021
-
-121.25%(-5.1%)
Jun 2021
-
-127.82%(-13.0%)
Mar 2021
-
-146.99%(-0.2%)
Dec 2020
-299.13%(+104.9%)
-147.32%(+8.4%)
Sep 2020
-
-135.90%(+5.9%)
Jun 2020
-
-128.28%(+2.9%)
Mar 2020
-
-124.69%(-8.3%)
Dec 2019
-145.96%
-136.04%(+63.4%)
DateAnnualQuarterly
Sep 2019
-
-83.25%(-6.6%)
Jun 2019
-
-89.16%(+7.5%)
Mar 2019
-
-82.92%(-11.9%)
Dec 2018
-84.28%(+45.1%)
-94.17%(+32.4%)
Sep 2018
-
-71.12%(-4.7%)
Jun 2018
-
-74.63%(-13.7%)
Mar 2018
-
-86.47%(+28.4%)
Dec 2017
-58.09%(+0.9%)
-67.37%(-20.8%)
Sep 2017
-
-85.08%(+8.1%)
Jun 2017
-
-78.67%(+40.2%)
Mar 2017
-
-56.11%(-3.2%)
Dec 2016
-57.59%(-61.3%)
-57.99%(-33.5%)
Sep 2016
-
-87.14%(-3.2%)
Jun 2016
-
-90.01%(-53.1%)
Mar 2016
-
-191.82%(-93.1%)
Dec 2015
-148.86%(-485.7%)
-2784.26%(-4016.0%)
Sep 2015
-
71.10%(-74.0%)
Jun 2015
-
273.04%(+1370.3%)
Mar 2015
-
18.57%(+74.2%)
Dec 2014
38.59%(+12.8%)
10.66%
Dec 2013
34.20%
-

FAQ

  • What is CytomX Therapeutics annual return on equity?
  • What is the all time high annual ROE for CytomX Therapeutics?
  • What is CytomX Therapeutics annual ROE year-on-year change?
  • What is CytomX Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for CytomX Therapeutics?
  • What is CytomX Therapeutics quarterly ROE year-on-year change?

What is CytomX Therapeutics annual return on equity?

The current annual ROE of CTMX is -6988.82%

What is the all time high annual ROE for CytomX Therapeutics?

CytomX Therapeutics all-time high annual return on equity is 25.24 K%

What is CytomX Therapeutics annual ROE year-on-year change?

Over the past year, CTMX annual return on equity has changed by -6990.02% (-582501.67%)

What is CytomX Therapeutics quarterly return on equity?

The current quarterly ROE of CTMX is -146.84%

What is the all time high quarterly ROE for CytomX Therapeutics?

CytomX Therapeutics all-time high quarterly return on equity is 296.81%

What is CytomX Therapeutics quarterly ROE year-on-year change?

Over the past year, CTMX quarterly return on equity has changed by 0.00% (0.00%)